Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12. (2012)

First Author: McCaig AM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0048929

PubMed Identifier: 23133664

Publication URI: http://europepmc.org/abstract/MED/23133664

Type: Journal Article/Review

Volume: 7

Parent Publication: PloS one

Issue: 11

ISSN: 1932-6203